Dapagliflozin therapy helps reduce CV mortality in heart failure with improved ejection fraction: JAMA Written By Medha Baranwal1 Feb 2024 11:00 AM ISTUSA: Adding a sodium-glucose transport protein 2 inhibitor therapy to other guideline-directed medical therapies may help lower cardiovascular...
Low-Dose Sulphonylurea and DPP4 Inhibitor Combo lowers blood sugar by augmentating beta cell function Written By Dr Riya Dave1 Feb 2024 10:45 AM ISTIn the pursuit of refining diabetes treatment, a recent unblinded randomized crossover study explored the potential synergy between low-dose...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections Written By Dr. Brij Mohan Makkar1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Empagliflozin and semaglutide combination improves glycemic control and BP but not arterial stiffness Written By Jacinthlyn Sylvia1 Feb 2024 10:15 AM ISTA recent 32-week study investigated the effects of empagliflozin, semaglutide, and their combination on vascular function. This study published in the...
Flaxseed intake may improve glucose, hs-CRP, and triglyceride levels in coronary artery disease Written By Medha Baranwal31 Jan 2024 11:30 AM ISTIran: A recent meta-analysis published in Clinical Cardiology has shown that flaxseed supplementation may lower high-sensitivity C-reactive protein...
SGLT2 inhibitors use tied to lower risk of kidney stones in patients with type 2 diabetes Written By Medha Baranwal31 Jan 2024 11:15 AM ISTUSA: The use of SGLT2 inhibitors in adults with type 2 diabetes (T2D) may lower nephrolithiasis risk compared with GLP-1 receptor agonists or DPP4...
Sclerostin: A key protein for cardiovascular health in patients with type 2 diabetes Written By Niveditha Subramani31 Jan 2024 9:30 AM ISTType 2 diabetes (T2D) is a growing concern as the metabolic disorder is associated with an increased risk of cardiovascular disease (CVD) affecting...
Associations Between Female Reproductive Milestones and Later-life Diabetes and High Cholesterol Risk Written By Niveditha Subramani31 Jan 2024 9:00 AM ISTMetabolic health generally concerns with optimal levels of blood glucose, triglycerides, high-density lipoprotein (HDL) cholesterol, blood pressure,...
New biomarkers identified that may improve prediction of CVD in diabetes patients Written By Dr. Shravani Dali30 Jan 2024 10:15 AM ISTResearchers have identified 13 biomarkers beyond traditional prognostic factors that may significantly improve the prediction of cardiovascular risk...
Elevated Fasting Blood sugar Linked to Higher Readmissions in Elderly HF Patients Written By Jacinthlyn Sylvia29 Jan 2024 10:45 AM ISTA recent retrospective study underlined the significant link between elevated fasting blood glucose (FBG) levels and the likelihood of readmission...
Patients with adrenal incidentalomas and mild autonomous cortisol secretion may be at increased Risk of Vertebral Fractures Written By Dr Riya Dave28 Jan 2024 2:45 PM ISTA recent study conducted in four Italian endocrinology units revealed an increased risk of vertebral fractures (VFx) in patients with adrenal...
HbA1C strongly predicts risk of developing T2D in Overweight adolescents JAMA Written By Dr.Niharika Harsha B27 Jan 2024 10:15 AM ISTA recent retrospective cohort study conducted within a large California healthcare system has unveiled crucial insights into the escalating risk of...
